336 related articles for article (PubMed ID: 19671735)
1. Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.
Perez EA
Mol Cancer Ther; 2009 Aug; 8(8):2086-95. PubMed ID: 19671735
[TBL] [Abstract][Full Text] [Related]
2. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
Harrison MR; Holen KD; Liu G
Clin Adv Hematol Oncol; 2009 Jan; 7(1):54-64. PubMed ID: 19274042
[TBL] [Abstract][Full Text] [Related]
3. Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.
Danziger M; Noble H; Roque DM; Xu F; Rao GG; Santin AD
Adv Exp Med Biol; 2024; 1452():1-19. PubMed ID: 38805122
[TBL] [Abstract][Full Text] [Related]
4. TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
Fitzgerald DP; Emerson DL; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Silberman S; Palmieri D; Steeg PS
Mol Cancer Ther; 2012 Sep; 11(9):1959-67. PubMed ID: 22622283
[TBL] [Abstract][Full Text] [Related]
5. An update on the development on tubulin inhibitors for the treatment of solid tumors.
Yakkala PA; Rahaman S; Soukya PSL; Begum SA; Kamal A
Expert Opin Ther Targets; 2024 Mar; 28(3):193-220. PubMed ID: 38618889
[TBL] [Abstract][Full Text] [Related]
6. The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy.
Cui Y; Zhang J; Zhang G
Curr Med Chem; 2024; 31(14):1874-1895. PubMed ID: 37349994
[TBL] [Abstract][Full Text] [Related]
7. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management.
Kita K; Burdowski A
World J Gastroenterol; 2024 Apr; 30(13):1780-1790. PubMed ID: 38659489
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity.
Williams NS; Burgett AW; Atkins AS; Wang X; Harran PG; McKnight SL
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2074-9. PubMed ID: 17287337
[TBL] [Abstract][Full Text] [Related]
9. Microtubule destabilising agents: far more than just antimitotic anticancer drugs.
Bates D; Eastman A
Br J Clin Pharmacol; 2017 Feb; 83(2):255-268. PubMed ID: 27620987
[TBL] [Abstract][Full Text] [Related]
10. Microtubules and resistance to tubulin-binding agents.
Kavallaris M
Nat Rev Cancer; 2010 Mar; 10(3):194-204. PubMed ID: 20147901
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-binding agents: a dynamic field of cancer therapeutics.
Dumontet C; Jordan MA
Nat Rev Drug Discov; 2010 Oct; 9(10):790-803. PubMed ID: 20885410
[TBL] [Abstract][Full Text] [Related]
12. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Jordan A; Hadfield JA; Lawrence NJ; McGown AT
Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
[TBL] [Abstract][Full Text] [Related]
13. Tubulin inhibitors: a patent review.
Liu YM; Chen HL; Lee HY; Liou JP
Expert Opin Ther Pat; 2014 Jan; 24(1):69-88. PubMed ID: 24313741
[TBL] [Abstract][Full Text] [Related]
14. Identification of a class of novel tubulin inhibitors.
Yi X; Zhong B; Smith KM; Geldenhuys WJ; Feng Y; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2012 Apr; 55(7):3425-35. PubMed ID: 22435708
[TBL] [Abstract][Full Text] [Related]
15. Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.
Rohena CC; Mooberry SL
Nat Prod Rep; 2014 Mar; 31(3):335-55. PubMed ID: 24481420
[TBL] [Abstract][Full Text] [Related]
16. An overview of tubulin inhibitors that interact with the colchicine binding site.
Lu Y; Chen J; Xiao M; Li W; Miller DD
Pharm Res; 2012 Nov; 29(11):2943-71. PubMed ID: 22814904
[TBL] [Abstract][Full Text] [Related]
17. New insights into mechanisms of resistance to microtubule inhibitors.
Ganguly A; Cabral F
Biochim Biophys Acta; 2011 Dec; 1816(2):164-71. PubMed ID: 21741453
[TBL] [Abstract][Full Text] [Related]
18. Drugs that target dynamic microtubules: a new molecular perspective.
Stanton RA; Gernert KM; Nettles JH; Aneja R
Med Res Rev; 2011 May; 31(3):443-81. PubMed ID: 21381049
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
